CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,131,626 | +37.7% | 408,575 | +12.5% | 0.00% | 0.0% |
| Q2 2023 | $8,082,691 | -7.5% | 363,267 | -10.0% | 0.00% | 0.0% |
| Q1 2023 | $8,738,316 | -9.3% | 403,431 | -14.9% | 0.00% | 0.0% |
| Q4 2022 | $9,631,023 | -11.0% | 474,201 | +12.4% | 0.00% | -33.3% |
| Q3 2022 | $10,820,000 | +47.4% | 421,993 | +36.7% | 0.00% | +50.0% |
| Q2 2022 | $7,339,000 | -6.5% | 308,640 | -11.5% | 0.00% | 0.0% |
| Q1 2022 | $7,850,000 | +7.7% | 348,586 | -5.3% | 0.00% | +100.0% |
| Q4 2021 | $7,287,000 | -35.7% | 368,046 | -36.1% | 0.00% | -50.0% |
| Q3 2021 | $11,330,000 | +25.6% | 575,683 | +40.4% | 0.00% | 0.0% |
| Q2 2021 | $9,018,000 | -21.7% | 409,935 | -15.3% | 0.00% | -33.3% |
| Q1 2021 | $11,515,000 | -32.6% | 484,016 | -25.9% | 0.00% | -40.0% |
| Q4 2020 | $17,079,000 | +105.8% | 652,873 | +37.0% | 0.01% | +150.0% |
| Q3 2020 | $8,298,000 | -48.7% | 476,714 | -50.4% | 0.00% | -60.0% |
| Q2 2020 | $16,160,000 | +57.6% | 960,711 | +11.4% | 0.01% | +25.0% |
| Q1 2020 | $10,251,000 | +82.5% | 862,130 | +85.8% | 0.00% | +300.0% |
| Q4 2019 | $5,616,000 | +40.7% | 464,111 | +64.4% | 0.00% | 0.0% |
| Q3 2019 | $3,991,000 | +67.3% | 282,325 | +31.9% | 0.00% | 0.0% |
| Q2 2019 | $2,386,000 | -63.0% | 213,970 | -61.1% | 0.00% | -50.0% |
| Q1 2019 | $6,455,000 | -16.6% | 549,837 | -5.1% | 0.00% | 0.0% |
| Q4 2018 | $7,744,000 | -3.8% | 579,631 | +0.9% | 0.00% | 0.0% |
| Q3 2018 | $8,053,000 | -39.0% | 574,400 | -31.6% | 0.00% | -50.0% |
| Q2 2018 | $13,195,000 | +41.6% | 839,377 | +48.1% | 0.00% | +100.0% |
| Q1 2018 | $9,321,000 | -23.8% | 566,602 | -16.3% | 0.00% | -33.3% |
| Q4 2017 | $12,231,000 | -15.7% | 677,232 | -9.9% | 0.00% | 0.0% |
| Q3 2017 | $14,505,000 | +350.6% | 751,563 | +175.5% | 0.00% | +200.0% |
| Q2 2017 | $3,219,000 | +36.5% | 272,815 | +26.7% | 0.00% | 0.0% |
| Q1 2017 | $2,359,000 | +145.7% | 215,292 | +62.8% | 0.00% | – |
| Q4 2016 | $960,000 | +18.4% | 132,266 | +6.0% | 0.00% | – |
| Q3 2016 | $811,000 | +144.3% | 124,793 | +105.5% | 0.00% | – |
| Q2 2016 | $332,000 | +39.5% | 60,719 | +19.2% | 0.00% | – |
| Q1 2016 | $238,000 | -2.5% | 50,954 | +3.6% | 0.00% | – |
| Q4 2015 | $244,000 | +130.2% | 49,177 | +74.7% | 0.00% | – |
| Q3 2015 | $106,000 | -49.8% | 28,154 | -19.7% | 0.00% | – |
| Q2 2015 | $211,000 | -53.8% | 35,069 | -78.5% | 0.00% | – |
| Q2 2014 | $457,000 | +277.7% | 163,159 | +488.7% | 0.00% | – |
| Q1 2014 | $121,000 | +72.9% | 27,717 | +27.3% | 0.00% | – |
| Q4 2013 | $70,000 | +191.7% | 21,775 | +41.9% | 0.00% | – |
| Q3 2013 | $24,000 | -65.7% | 15,350 | -68.8% | 0.00% | – |
| Q4 2012 | $70,000 | +16.7% | 49,124 | +130.3% | 0.00% | – |
| Q3 2012 | $60,000 | -59.5% | 21,330 | -35.3% | 0.00% | – |
| Q2 2012 | $148,000 | -67.1% | 32,957 | -71.2% | 0.00% | – |
| Q1 2012 | $450,000 | – | 114,358 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
| Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
| Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| S&T BANK/PA | 350,924 | $7,601 | 1.37% |
| Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
| Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
| Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |